Muhrat Al Marasim
Turnkey Regulatory Architectures

Strategic regulatory solutions for Saudi Arabia.

حلول تنظيمية متكاملة لامتثال الأجهزة والمنتجات الطبية

From pre-submission gap assessments and ISO 13485 quality systems to unbundled Authorized Representation and 24/7 post-market vigilance, we build sovereign compliance infrastructure across the Middle East.

Market AccessStep 01 - 04

Market Access & Strategic Registration

الوصول إلى الأسواق والتسجيل الاستراتيجي

Achieve compliant, predictable market entry. Muhrat Al Marasim bridges foreign medical manufacturers with national regulators (SFDA, UAE MoHAP, NHRA Bahrain, MoH Kuwait). We engineer the optimal registration pathway to minimize time-to-market while safeguarding intellectual property.

Regulatory Gap Analysis & Roadmap: Thorough pre-submission auditing of technical files, labeling, and clinical...
Classification Matrix Optimization: Accurately categorizing device risk profiles to prevent over-classification...
Direct Agency Advocacy: Dedicated liaison officers managing daily interactions with SFDA review pan...
Architecture Deep Dive
Muhrat RegiProStep 01 - 03

Muhrat RegiPro: Outsourced RA Department

مهرة ريجي برو: قسم الشؤون التنظيمية المخصص

Muhrat RegiPro is an executive subscription model providing international healthcare corporations with a dedicated regional regulatory team. From routine variations and promotional material reviews to emergency recalls and distributor oversight, RegiPro ensures perpetual compliance.

Dedicated Regulatory Director: Senior regulatory strategist assigned to your portfolio with bilingual flue...
Continuous Horizon Scanning: Real-time alerts on forthcoming SFDA regulations, fee adjustments, and mand...
Distributor Compliance Audits: Ensuring your appointed local commercial distributors adhere strictly to GD...
Architecture Deep Dive
ISO 13485 & QMSStep 01 - 04

QMS, ISO 13485 & GDP Certification

أنظمة إدارة الجودة وشهادات الآيزو وممارسات التوزيع الجيد

Quality Management Systems are the bedrock of regulatory approvals. We build, audit, and remediate QMS architectures complying with ISO 13485:2016, ISO 9001, SFDA Good Distribution Practice (GDP), and Good Storage Practice (GSP).

ISO 13485:2016 QMS Implementation: Complete documentation authoring, quality manuals, standard operating proce...
Warehouse & GDP Licensing (MDEL): Preparation of medical storage facilities, temperature mapping, pest contro...
Pre-Audit Mock Inspections: Simulated notified body and SFDA auditor visits to identify non-conformance...
Architecture Deep Dive
Technical FilesStep 01 - 03

Technical File Authoring & Gap Remediation

إعداد الملفات الفنية ومعالجة الفجوات التنظيمية

A regulatory submission is only as resilient as its underlying technical file. Muhrat Al Marasim authors, reviews, and upgrades technical documentation to withstand scientific scrutiny from SFDA review committees.

ISO 14971 Risk Management Files: Authoring comprehensive risk management plans, FMEA matrices, and risk-bene...
Essential Principles Conformity: Detailed evidence matrices demonstrating compliance with safety, performanc...
Biocompatibility & Sterilization Validation: Review of ISO 10993 biological evaluations, ethylene oxide residuals, gamma...
Architecture Deep Dive
Clinical ResearchStep 01 - 03

Clinical Evaluation & Evidence Generation

التقييم السريري وتوليد الأدلة الطبية

Robust clinical data is imperative for Class IIb and Class III marketing authorizations. We produce state-of-the-art Clinical Evaluation Reports (CER) aligned with MEDDEV 2.7/1 Rev. 4 and EU MDR Article 61.

Clinical Evaluation Reports (CER): Systematic literature searches, equivalence demonstrations, and clinical sa...
SFDA Clinical Trial Authorizations: Compilation and ethics committee (IRB) clearance for local clinical trials ...
Post-Market Clinical Follow-Up (PMCF): Designing registries, user surveys, and observational studies to fulfill po...
Architecture Deep Dive
Post-Market VigilanceStep 01 - 03

Post-Market Vigilance & Supply Operations

اليقظة الدوائية والرقابة بعد التسويق وعمليات الإمداد

Securing marketing approval is merely the starting line. Muhrat Al Marasim manages the demanding post-market regulatory environment, protecting your brand reputation and maintaining unbroken market presence.

24/7 Saudi Vigilance Hotline: Mandatory local incident intake, Saudi Vigilance portal reporting, and caus...
Field Safety Corrective Actions (FSCA): Managing product recalls, field safety notices (FSN), and customer communic...
Customs Import Release Permits: FASAH platform synchronization, batch verification, and port clearance faci...
Architecture Deep Dive
Interactive Methodology

Step-by-Step Execution Architecture.

Select any solution below to inspect the sequential review phases, regulatory touchpoints, and expected milestone outputs.

Active Architecture

Market Access & Strategic Registration

Unlocking Market Velocity Across Saudi Arabia and the Gulf Cooperation Council

01
Dossier Screening
We audit existing CE MDR / US FDA 510(k)/PMA dossiers against Saudi specific requirements.
02
TFA Compilation
Assembly of the Technical File Assessment with essential principles and bilingual IFUs.
03
GHAD Submission
Electronic filing and tracking through official Saudi regulatory portals.
04
Marketing License
Issuance of official MDMA certificate granting immediate customs clearance and commercial sale rights.
Target Strategic Outcomes:
Over 98% first-pass review acceptance rate with SFDA
Average 40% reduction in regulatory turnaround cycle
Full ownership and control of your marketing licenses